Location
Boston, MA
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
21
Total value ($000)
$1,682,021
Net value change ($000)
+573,205 (51.7%)
New positions
2
Sold out positions
1
Turnover %
34.7%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 5/15/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
KAILERA THERAPEUTICS INC 497,509 NEW
ALKERMES PLC 79,968 370.7%
HEMAB THERAPEUTICS HOLDINGS INC 60,605 NEW
CABA 27,590 106.0%
SLDB 27,367 38.8%
PHVS 16,936 22.4%
CCCC 14,631 77.6%
SVRA 12,321 12.8%
DNTH 4,916 16.2%
XFOR 4,302 13.1%
Top Reduces (Value $000, Stocks/ETFs)
NAMS -104,878 -44.8%
CNTA -25,222 -100.0%
OLMA -22,790 -20.5%
HTFL -6,335 -2.5%
RPID -4,554 -23.8%
UPB -3,646 -46.7%
ANNX -3,539 -12.3%
AVIR -3,048 -24.0%
KYTX -1,134 -4.2%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type